Specialty Pharmacy

Researchers evaluate how PTEN protein regulates cell growth and how mutations can lead to cancer.

Nano sensor able to catch MS in early development.

Data tracking may someday become a key component in limiting disease spread.

Cabozantinib is a potential treatment for patients with advanced renal cell carcinoma who received one prior therapy.

Researchers shed light on association between alcohol consumption and cancer.

Two different dose prescriptions achieve similar results.

Doppler system correctly identified 100% of patients with malignant skin cancer.

Cancer drug significantly reduces the risk for clinically relevant non-major bleeding.

Promacta use now includes young children with chronic immune thrombocytopenia.

Findings could lead to more effective treatments for diseases such as cancer and multiple sclerosis.

Treatment seeks to teach the immune system to ignore a peptide that leads to inflammation.

New cancer detection technique may reduce the need for costly low-dose CT scans.

The FDA has accepted Allergan's resubmission to approve the use of onabotulinumtoxinA (Botox) for lower limb spasticity in adults.

Processing speed found to hinder MS patients in everyday life.

Process could lead to new treatments for diabetes and other diseases.

Proper nutrition leads to improved outcomes and increased CD4 T-cell counts.

Researchers evaluate how cancer cells adapt and survive in a new bone environment.

Walgreens will pay a $500,000 settlement concerning a civil complaint that the retail pharmacy giant was not compliant with California regulations related to pharmacist consultations.

Each year, the American Society of Health-System Pharmacists provides a tremendous service to pharmacists by publishing a list of significant articles on infectious diseases pharmacotherapy from the previous year.

Ongoing clinical trial testing guadecitabine in Myelodysplastic syndromes and acute myelogenous leukemia.

Epidermal growth factor receptors may offer cancer treatment target.

A look back at recent developments in cancer research.

A regular dose of aspirin may reduce the risk of early cancer development.

An HCV infection may cause more than just liver damage.

Children vaccinated before starting HIV therapy found to be at risk.

Top stories of the week on Specialty Pharmacy Times from August 17 to 21.

Out-of-pocket costs projected to drop from 11.6% in 2013 to 10% in 2024.

Treatment uses photodynamic therapy with compounds that make cancer cells vulnerable to reactive oxygen species.